The English NHSCSP will shortly announce a move from primary screening with cytology to
testing for human papillomavirus (HPV). This, despite evidence that HPV testing has a …

Introduction. Cervical cancer is the fourth most common cancer among women. It is related
to persistent HPV infection. In order to improve diagnostic methods, a lot of research has …

Background Human papillomavirus (HPV) testing as primary screening for cervical cancer is
currently being implemented in Norway in a randomized controlled fashion, involving three …

In 2017 in France, cervical cancer (CC) was diagnosed in 2850 women and 1100 women
died. The decline in incidence and mortality rates observed for several decades has slowed …

Two main considerations played roles in creation of new cervical screening system. One
was the proven fact that high-risk human papilloma virus infection plays a role in the …

The role of high-risk human papillomavirus (hrHPV) testing in primary cervical screening has
not been established. We generated a randomised evaluation design ultimately to clarify …

Objective To compare primary test positivity in cytology and human papillomavirus-based
screening between different Nordic cervical cancer screening programs using harmonized …

Introduction High‐risk human papilloma virus (hrHPV) DNA testing is more sensitive than
cytology screening, achieving greater protection against cervical cancer. Controversy exists …

Objective We report performance indicators and costs of the first round of a cervical cancer
screening programme based on the human papillomavirus (HPV)-DNA test. Methods We …

Cervical screening has been one of the most successful public health prevention
programmes. For 50 years, cytology formed the basis for screening, and detected cervical …